Financials Al-Razi Medical Company

Equities

9572

SA15R0E4LI18

Medical Equipment, Supplies & Distribution

Market Closed - Saudi Arabian S.E. 08:35:21 04/07/2024 BST 5-day change 1st Jan Change
52 SAR +7.22% Intraday chart for Al-Razi Medical Company +8.00% -13.04%

Valuation

Fiscal Period: December 2023
Capitalization 1 90.9
Enterprise Value (EV) 1 100.7
P/E ratio 133 x
Yield -
Capitalization / Revenue 1.48 x
EV / Revenue 1.64 x
EV / EBITDA 36 x
EV / FCF -371,731,698 x
FCF Yield -0%
Price to Book 4.06 x
Nbr of stocks (in thousands) 1,520
Reference price 2 59.80
Announcement Date 04/04/24
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 45.19 52.39 61.33
EBITDA 1 3.316 3.636 2.8
EBIT 1 2.42 2.574 1.372
Operating Margin 5.36% 4.91% 2.24%
Earnings before Tax (EBT) 1 2.533 2.425 1.086
Net income 1 2.163 2.014 0.686
Net margin 4.79% 3.84% 1.12%
EPS 2 1.423 1.325 0.4513
Free Cash Flow - -1.885 -0.271
FCF margin - -3.6% -0.44%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 26/02/23 26/02/23 04/04/24
1SAR in Million2SAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - 6.09 9.84
Net Cash position 1 1.21 - -
Leverage (Debt/EBITDA) - 1.676 x 3.515 x
Free Cash Flow - -1.88 -0.27
ROE (net income / shareholders' equity) - 8.43% 2.98%
ROA (Net income/ Total Assets) - 3.88% 1.94%
Assets 1 - 51.88 35.31
Book Value Per Share 2 15.90 15.50 14.70
Cash Flow per Share 2 5.120 1.000 0.5600
Capex 1 1.11 2.69 4.78
Capex / Sales 2.46% 5.14% 7.79%
Announcement Date 26/02/23 26/02/23 04/04/24
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 9572 Stock
  4. Financials Al-Razi Medical Company